Literature DB >> 10600645

Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.

M Safran1, M Eisenstein, D Aviezer, A Yayon.   

Abstract

The biological response of cells to fibroblast growth factors (FGFs) depends on heparan sulphate glycosaminoglycans sharing particular structural motifs. Heparin induced FGF dimerization has been suggested to mediate receptor dimerization and activation. Here we demonstrate that heparin-derived oligosaccharides that promote receptor binding and activation specifically induce the dimerization of basic FGF (FGF2). These heparin-induced dimers of FGF2 acquire high affinity for receptor binding and are biologically active. Using biotinylated FGF2 bound to immobilized streptavidin gradually saturated with biotin, enabled a quantitative analysis of heparin-dependent and heparin-independent FGF2 monomers and oligomers. Streptavidin induced FGF2 dimers bind and activate FGF receptors only in the presence of heparin. An excess of streptavidin, forcing biotin-FGF2 into monomers, reduces receptor binding and blocks FGF-dependent cell proliferation. All these suggest predominant receptor binding and activation by heparin associated FGF2 oligomers. Unexpectedly, heparin induced dimers and higher order oligomers lose most of their affinity towards heparin. Direct binding of soluble FGF receptors (FGFRs) to either monomers or dimers of FGF2, immobilized on heparin, confirm the preferred association of FGFRs with dimers of FGF2. Computerized molecular docking predicts a cis-oriented FGF2 dimer, stabilized by heparin, which complies with all the experimental data.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10600645      PMCID: PMC1220736     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  55 in total

1.  Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques.

Authors:  E Katchalski-Katzir; I Shariv; M Eisenstein; A A Friesem; C Aflalo; I A Vakser
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 2.  Proteoglycans as modulators of growth factor activities.

Authors:  E Ruoslahti; Y Yamaguchi
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

3.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.

Authors:  A C Rapraeger; A Krufka; B B Olwin
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

4.  Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo.

Authors:  S R Coughlin; P J Barr; L S Cousens; L J Fretto; L T Williams
Journal:  J Biol Chem       Date:  1988-01-15       Impact factor: 5.157

5.  Three-dimensional structure of human basic fibroblast growth factor.

Authors:  A E Eriksson; L S Cousens; L H Weaver; B W Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

7.  Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.

Authors:  J D Zhang; L S Cousens; P J Barr; S R Sprang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

8.  Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.

Authors:  D M Ornitz; A Yayon; J G Flanagan; C M Svahn; E Levi; P Leder
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

Review 9.  The fibroblast growth factor family: structural and biological properties.

Authors:  M Klagsbrun
Journal:  Prog Growth Factor Res       Date:  1989

Review 10.  Recent developments in the cell biology of basic fibroblast growth factor.

Authors:  D B Rifkin; D Moscatelli
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  6 in total

1.  Fibroblast growth factor 2 dimer with superagonist in vitro activity improves granulation tissue formation during wound healing.

Authors:  Caitlin G Decker; Yu Wang; Samantha J Paluck; Lu Shen; Joseph A Loo; Alex J Levine; Lloyd S Miller; Heather D Maynard
Journal:  Biomaterials       Date:  2015-12-15       Impact factor: 12.479

2.  Secreted proteoglycans directly mediate human embryonic stem cell-basic fibroblast growth factor 2 interactions critical for proliferation.

Authors:  Mark E Levenstein; W Travis Berggren; Ji Eun Lee; Kevin R Conard; Rachel A Llanas; Ryan J Wagner; Lloyd M Smith; James A Thomson
Journal:  Stem Cells       Date:  2008-09-18       Impact factor: 6.277

3.  Fibroblast Growth Factor-2 Binding to Heparan Sulfate Proteoglycans Varies with Shear Stress in Flow-Adapted Cells.

Authors:  Jonathan Garcia; Nisha Patel; Sarah Basehore; Alisa Morss Clyne
Journal:  Ann Biomed Eng       Date:  2019-01-28       Impact factor: 3.934

4.  Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene.

Authors:  Xiao-Lin Wu; Ming-Min Gu; Lei Huang; Xue-Song Liu; Hong-Xin Zhang; Xiao-Yi Ding; Jian-Qiang Xu; Bin Cui; Long Wang; Shun-Yuan Lu; Xiao-Yi Chen; Hai-Guo Zhang; Wei Huang; Wen-Tao Yuan; Jiang-Ming Yang; Qun Gu; Jian Fei; Zhu Chen; Zhi-Min Yuan; Zhu-Gang Wang
Journal:  Am J Hum Genet       Date:  2009-07       Impact factor: 11.025

5.  A Heparin-Mimicking Block Copolymer Both Stabilizes and Increases the Activity of Fibroblast Growth Factor 2 (FGF2).

Authors:  Samantha J Paluck; Thi H Nguyen; Jonghan P Lee; Heather D Maynard
Journal:  Biomacromolecules       Date:  2016-09-13       Impact factor: 6.988

6.  Stable Fibroblast Growth Factor 2 Dimers with High Pro-Survival and Mitogenic Potential.

Authors:  Daria Nawrocka; Mateusz Adam Krzyscik; Łukasz Opaliński; Malgorzata Zakrzewska; Jacek Otlewski
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.